File: '\\swfile\EmailIn\20260910 050107 Attachment 20260910 - 11. Frequency Exchange Commercialization Update.docx'

FREQUENCY EXCHANGE CORP. ENTERS KEY COMMERCIALIZATION PHASE FOR NIKKI, IT'S WEARABLE WELLNESS DEVICE

Multiple NIKKI Initiatives Scheduled to Launch Beginning in September

VANCOUVER, British Columbia, September 10, 2026 - Frequency Exchange Corp. (TSXV: FREQ | OTC: FRECF | FSE: YC6) ("Frequency Exchange" or the "Company") is pleased to provide an update on the continued commercialization of NIKKI, the Company's wearable frequency-based wellness platform.

September marks the beginning of what the Company believes will be its most active commercialization period to date.

From September through mid-October, Frequency Exchange expects NIKKI to move into the market across several fronts:

U.S. Practitioner Launch: Access to more than 7,000 practitioner clinics, creating a significant new channel for NIKKI.

United Arab Emirates: Advancing the Company's commercial activities and building NIKKI's presence in the UAE.

Best Buy Marketplace Online Store, Phase One: Preparing for the initial online launch of NIKKI through Best Buy Marketplace, representing the first phase of the Company's retail commercialization strategy and an important step toward broader consumer access.

Superhuman 2: REBIRTH: NIKKI will be featured in Superhuman 2: REBIRTH, providing international exposure for the technology and platform.

Three Wellness Events: Direct exposure to consumers, wellness leaders and potential strategic partners.

Three Los Angeles Premieres: Superhuman 2 premieres are planned in Los Angeles during the first two weeks of October 2026.

Dallas Investor Event: An opportunity to introduce Frequency Exchange Corp. and the NIKKI commercialization story directly to a broader investment audience.

"Over the past several months, we have been putting the pieces in place for commercialization. Beginning in September, those pieces start moving into the market," said Stephen Davis, CEO of Frequency Exchange Corp. "This is no longer simply about preparing NIKKI for commercialization. Commercialization is beginning."

Financing Update

The Company is currently completing a C$2 million financing at C$0.25 per share, with each share accompanied by one-half of a common share purchase warrant. Each full warrant is exercisable at C$0.40 per share for a period of one year, subject to the terms of the financing and applicable regulatory approvals.

The Company began actively raising the financing and has price protection for 30 days. We have now exceeded commitments over C$700,000.

"With multiple initiatives scheduled to begin launching in September and market activity building through the Christmas season, we believe this financing comes at an important stage in Frequency Exchange's development," added Davis. "Our focus is execution, inventory, distribution, consumer awareness and supporting the opportunities now in front of us."

About Frequency Exchange Corp.

Frequency Exchange Corp. (TSXV: FREQ | OTC: FRECF | FSE: YC6) is a technology company building the next generation of wearable digital wellness solutions through its flagship platform, NIKKI. Unlike traditional wearable devices that primarily monitor health metrics, NIKKI delivers personalized frequency-based wellness programs designed to support sleep, stress, recovery, energy and overall wellbeing. Originally developed through research supporting individuals living with Lyme disease, NIKKI has evolved into a scalable wearable digital wellness platform addressing some of today's largest global health challenges.

For additional information, visit www.frequencyexchangecorp.com or www.wearenikki.com

More information is available at:

www.FrequencyExchangeCorp.com

www.WeAreNikki.com

Investor Contacts

Frequency Exchange Corp. Frequency Health Technologies Inc.

Stephen Davis Nicole Sullivan

Chief Executive Officer President

stephen@frequencyexchangecorp.com nicole.sullivan@wearenikki.com

604-684-2181 604-684-2181

Forward-Looking Information

This news release contains forward-looking information and forward-looking statements within the meaning of applicable Canadian securities legislation. Such statements include, but are not limited to, statements regarding the timing and scope of the Company's commercialization activities, product launches, retail initiatives, international expansion, events, exposure through Superhuman 2: REBIRTH, completion of the Company's financing, use of proceeds, inventory, distribution and future growth.

Forward-looking statements are based on management's current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update such statements except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.